Variant · Snv
RET C609Y
CI-VAR-00000326Explore in graph →NP_065681.1:p.Cys609TyrNM_020630.4:c.1826G>AClinVar 13933 CIViC 1260 rs77939446
Curated evidence
Evidence by cancer (2 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 19472011
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Thyroid Gland Medullary Carcinoma2 | ||||||||
| RET C609Y | (predisposing) | Predisposing | B | Supports Predisposition | 4 | accepted | EID2913Study of a family with three generations of history indicating co-segregation of RET C609Y and multiple endocrine neoplasia type 2A, many of whom exhibited medullary thyroid cancers specifically. 22 … (full text at CIViC) PMID 19472011 · Calva et al., 2009 · Open in CIViC | civic |
| RET C609Y | (predisposing) | Predisposing | E | Supports Uncertain Significance | 3 | submitted | EID2914This study performed various functional characterizations of several RET mutations known to occur as pathogenic germline variants in multiple endocrine neoplasia type 2 and medullary thyroid cancer. S… (full text at CIViC) PMID 16715139 · Mise et al., 2006 · Open in CIViC | civic |
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 13933 | Pathogenic | criteria provided, multiple submitters, no conflicts | 2 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITH HIRSCHSPRUNG DISEASE; Multiple endocrine neoplasia, type 2; Multiple endocrine neoplasia type 2A; Familial medullary thyroid carcinoma; Hereditary cancer-predisposing syndrome; Hirschsprung disease, susceptibility to, 1; RET-related disorder | germline | 21 | Jan 13, 2026 |